Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4
Clinical trial NCT02634580 · COMPLETED
Trial details
- NCT number
- NCT02634580
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-27
- Primary completion
- 2017-08-10
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.